Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Carrier Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global carrier screening market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Carrier screening is a genetic testing technique used for the identification abnormal genes in fetuses that can cause autosomal recessive diseases. It is a predictive and pre-symptomatic testing solution used by pregnant individuals and couples to analyze the risks of their child inheriting genetic disorders from the parents. It involves testing a sample of saliva, blood or cheek tissue to detect the presence of an abnormal gene for disorders, such as cystic fibrosis, sickle cell anemia and Tay-Sachs disease. These samples are screened through molecular and biochemical processes based on deoxyribonucleic acid (DNA) sequencing, polymerase chain reaction (PCR) and microarray technologies. They are used for expanded, customized panel, predesigned panel and targeted disease carrier screening for various pulmonary, hematological and neurological disorders.

Carrier Screening Market Trends:

The increasing prevalence of fetal chromosomal abnormalities and genetic disorders across the globe is one of the key factors driving the growth of the market. Moreover, the rising consciousness among the masses regarding the benefits of early detection and diagnosis of diseases is providing a thrust to the market growth. In line with this, molecular screening tests are widely conducted to identify DNA mutations in the genetic codes and detect the mutations that can cause heart defects, pre-leukemia, hearing defects and down syndrome. Carrier screening also aids in providing adequate prenatal and reproductive care, which facilitates the proper management of heritable diseases. Additionally, various technological advancements, such as the development of next-generation sequencing (NGS) techniques for genetic disease screening, are also favoring the market growth. Other factors, including extensive research and development (R&D) activities in the field of biotechnology and bioinformatics, along with significant growth in the medical infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global carrier screening market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, medical condition, technology and end user.

Breakup by Type:

  • Expanded Carrier Screening
    • Customized Panel Testing
    • Predesigned Panel Testing
  • Targeted Disease Carrier Screening
     

Breakup by Medical Condition:

  • Pulmonary Conditions
  • Hematological Conditions
  • Neurological Conditions
  • Others
     

Breakup by Technology:

  • DNA Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Others
     

Breakup by End User:

  • Hospitals and Clinics
  • Reference Laboratories
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Fulgent Genetics, Gene By Gene Ltd. (MyDNA), Illumina Inc., Invitae Corporation, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Quest Diagnostics, Sema4 and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Type, Medical Condition, Technology, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Fulgent Genetics, Gene By Gene Ltd. (MyDNA), Illumina Inc., Invitae Corporation, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Quest Diagnostics, Sema4 and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global carrier screening market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global carrier screening market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the medical condition?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global carrier screening market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Carrier Screening Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    Expanded Carrier Screening
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Customized Panel Testing
           6.1.2.2 Predesigned Panel Testing
        6.1.3 Market Forecast
    6.2    Targeted Disease Carrier Screening
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Medical Condition
    7.1    Pulmonary Conditions
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Hematological Conditions
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Neurological Conditions
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by Technology
    8.1    DNA Sequencing
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Polymerase Chain Reaction
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Microarrays
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by End User
    9.1    Hospitals and Clinics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Reference Laboratories
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Fulgent Genetics
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
        15.3.2    Gene By Gene Ltd. (MyDNA)
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Illumina Inc.
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Invitae Corporation
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
        15.3.5    MedGenome Labs Ltd.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Myriad Genetics Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Natera Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
        15.3.8    OPKO Health Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Quest Diagnostics
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Sema4
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
        15.3.11    Thermo Fisher Scientific Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Carrier Screening Market: Major Drivers and Challenges
Figure 2: Global: Carrier Screening Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Carrier Screening Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Carrier Screening Market: Breakup by Type (in %), 2020
Figure 5: Global: Carrier Screening Market: Breakup by Medical Condition (in %), 2020
Figure 6: Global: Carrier Screening Market: Breakup by Technology (in %), 2020
Figure 7: Global: Carrier Screening Market: Breakup by End User (in %), 2020
Figure 8: Global: Carrier Screening Market: Breakup by Region (in %), 2020
Figure 9: Global: Carrier Screening (Expanded Carrier Screening) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Carrier Screening (Expanded Carrier Screening) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Carrier Screening (Targeted Disease Carrier Screening) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Carrier Screening (Targeted Disease Carrier Screening) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Carrier Screening (Pulmonary Conditions) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Carrier Screening (Pulmonary Conditions) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Carrier Screening (Hematological Conditions) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Carrier Screening (Hematological Conditions) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Carrier Screening (Neurological Conditions) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Carrier Screening (Neurological Conditions) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Carrier Screening (Other Medical Conditions) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Carrier Screening (Other Medical Conditions) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Carrier Screening (DNA Sequencing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Carrier Screening (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Carrier Screening (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Carrier Screening (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Carrier Screening (Microarrays) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Carrier Screening (Microarrays) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Carrier Screening (Other Technologies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Carrier Screening (Other Technologies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Carrier Screening (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Carrier Screening (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Carrier Screening (Reference Laboratories) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Carrier Screening (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Carrier Screening (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Carrier Screening (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: North America: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: North America: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: United States: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: United States: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Canada: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Canada: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Asia-Pacific: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Asia-Pacific: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: China: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: China: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Japan: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Japan: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: India: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: India: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: South Korea: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: South Korea: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Australia: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Australia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Indonesia: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Indonesia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Others: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Europe: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Europe: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Germany: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Germany: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: France: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: France: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: United Kingdom: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: United Kingdom: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Italy: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Italy: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Spain: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Spain: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Russia: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Russia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Others: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Latin America: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Latin America: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Brazil: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Brazil: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Mexico: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Mexico: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Others: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Middle East and Africa: Carrier Screening Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Middle East and Africa: Carrier Screening Market: Breakup by Country (in %), 2020
Figure 83: Middle East and Africa: Carrier Screening Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 84: Global: Carrier Screening Industry: SWOT Analysis
Figure 85: Global: Carrier Screening Industry: Value Chain Analysis
Figure 86: Global: Carrier Screening Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Carrier Screening Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Carrier Screening Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: Global: Carrier Screening Market Forecast: Breakup by Medical Condition (in Million US$), 2021-2026
Table 4: Global: Carrier Screening Market Forecast: Breakup by Technology (in Million US$), 2021-2026
Table 5: Global: Carrier Screening Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 6: Global: Carrier Screening Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Carrier Screening Market: Competitive Structure
Table 8: Global: Carrier Screening Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links